|
R&D Pipeline News Vol. 2, Issue 21: Update on Erythropoiesis-Stimulating Agents (ESA) |
|
|
|
02 Jun 2006 |
Read the highlights of the most recent edition of our weekly R&D information product R&D Pipeline News. The Special Product or Technology Pipelines of R&D Pipeline News are available via subscription of R&D Pipeline News or as a single Project Pipeline List .
 |
| |
Special Company Pipelines:
|
Vol. 2 Issue nº 21
June 02, 2006
|
 |
|
|
R&D Pipeline News
|
|
|
|
|
|
Special Company Pipelines
|
Kirin (Japan)
|
- Plans transformation into Holding structure with Kirin Pharma company for spin-off;
- Indication focus on renal diseases, oncology and infectious diseases;
- Technology focus on KM human antibody focus and cell therapy /vaccines;
- TRAIL-R2 antibody first clinical stage antibody project;
- Recent pneumococcal antigen deal with Intercell;
- RNAi loaded dendritic cells for patient specific therapy of renal cell cancer
More Details inside R&D Pipeline News
Get you annual subscription and receive this issue for free!
|
Transition Therapeutics (Canada)
|
- Diabetes collaboration with Novo Nordisk;
- Islet neogenesis therapy using gastrin and growth factor or GLP-1 analogs;
- Interferon enhancing methyl donor therapy with use in multiple sclerosis and hepatitis C virus infection;
- Phase I Alzheimer study with amyloid beta disrupting agent
More Details inside R&D Pipeline News
Get you annual subscription and receive this issue for free!
(1) Related Report: Glucagon-like peptide-1 (GLP-1) analogs
|
|
R&D Pipeline News
Get your Subscription Now
|
R&D Pipeline News is a premier information source about research and development (R&D) projects in the pipeline of the biopharmaceutical industry and is directed to all stakeholders in R&D . R&D Pipeline News covers all relevant treatment modalities, including. drugs, medical devices, biomaterials, combination products, cell therapy and drug delivery products.
Read more about R&D Pipeline NewsOrder Now
 
|
|
|
|
|
|
|
|
 |
|
